Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Dayan

Showing results (1-10 of 209) with videos related to

Pageof 21
Sort By:
Journal of the Royal Society of Medicine|September 1, 1978
Uses and limitations of primates in the evaluation of drug efficacy and safetyA D Dayan
Human & Experimental Toxicology|November 1, 1991
How should we regard risks?A D Dayan
Medecine Tropicale : Revue Du Corps De Sante Colonial|April 23, 1999
Neurotoxicity and artemisinin compounds do the observations in animals justify limitation of clinical use?A D Dayan
Toxicology|December 20, 1995
Safety evaluation of biological and biotechnology-derived medicinesA D Dayan
International Journal of Experimental Pathology|December 1, 1996
Transgenic rodents in toxicologyA D Dayan
Postgraduate Medical Journal|February 26, 2009
What killed Socrates? Toxicological considerations and questionsA D Dayan
International Journal of Clinical Practice|August 9, 2006
Response to: Ethics, data and the pharmaceutical physicianA D Dayan
Proceedings of the Royal Society of Medicine|September 1, 1975
Effects of viruses and viral vaccines on the CNSA D Dayan
Veterinary Microbiology|June 1, 1993
Allergy to antimicrobial residues in food: assessment of the risk to manA D Dayan
Lancet (London, England)|February 24, 1973
Viral antigen in cells of lumbar cerebrospinal fluidA D Dayan
Pageof 21

Showing results (1-10 of 209) with videos related to

Sort By:
Pageof 21
Journal of the Royal Society of Medicine|September 1, 1978
Uses and limitations of primates in the evaluation of drug efficacy and safetyA D Dayan
Human & Experimental Toxicology|November 1, 1991
How should we regard risks?A D Dayan
Medecine Tropicale : Revue Du Corps De Sante Colonial|April 23, 1999
Neurotoxicity and artemisinin compounds do the observations in animals justify limitation of clinical use?A D Dayan
Toxicology|December 20, 1995
Safety evaluation of biological and biotechnology-derived medicinesA D Dayan
International Journal of Experimental Pathology|December 1, 1996
Transgenic rodents in toxicologyA D Dayan
Postgraduate Medical Journal|February 26, 2009
What killed Socrates? Toxicological considerations and questionsA D Dayan
International Journal of Clinical Practice|August 9, 2006
Response to: Ethics, data and the pharmaceutical physicianA D Dayan
Proceedings of the Royal Society of Medicine|September 1, 1975
Effects of viruses and viral vaccines on the CNSA D Dayan
Veterinary Microbiology|June 1, 1993
Allergy to antimicrobial residues in food: assessment of the risk to manA D Dayan
Lancet (London, England)|February 24, 1973
Viral antigen in cells of lumbar cerebrospinal fluidA D Dayan
Pageof 21